13484-56-5

Usage

Uses

Used in Pharmaceutical Industry:
3-Chloro-6-Methoxypyrazin-2-aMine is used as a building block in the synthesis of pharmaceuticals for its versatile chemical structure and potential health benefits.
Used in Agrochemical Industry:
3-Chloro-6-Methoxypyrazin-2-aMine is also utilized as a building block in the synthesis of agrochemicals, contributing to the development of new products for agricultural applications.
Used as a Flavoring Agent in Food and Beverage Industry:
3-Chloro-6-Methoxypyrazin-2-aMine is used as a flavoring agent in food and beverages due to its pleasant aroma and taste, enhancing the sensory experience of consumers.
Used in Research for Biological Activity:
3-Chloro-6-Methoxypyrazin-2-aMine has been studied for its potential antimicrobial and antioxidant properties, indicating its use in research and development for various health-related applications.

InChI:InChI=1S/C5H6ClN3O/c1-10-3-2-8-4(6)5(7)9-3/h2H,1H3,(H2,7,9)

Upstream product

• 6905-47-1 6-Methoxy-pyrazin-2-ylamine 

Relevant academic research and scientific papers

NEW ANTIBACTERIAL COMPOUNDS

The present invention relates to novel antibacterial compounds, pharmaceutical compositions containing them and their use as antimicrobials.

New heterocyclic analogues of 4-(2-chloro-5-methoxyanilino)quinazolines as potent and selective c-Src kinase inhibitors

A series of 5,7-disubstituted quinazolines, bearing 4-heteroaryl substituents such as 2-pyridinylamine or 2-pyrazinylamine, has been synthetised and evaluated as c-Src kinase inhibitors. Highly potent inhibition, high selectivity and physical properties suitable for oral dosing were achieved within this series: 23d and 42 were identified as sub-0.1 μM inhibitors in a c-Src-driven cell proliferation assay and displayed adequate rat pharmacokinetics after oral administration.

PYRAZINYL 3-CYANOQUINOLINE DERIVATIVES FOR USE IN THE TREATMENT OF TUMOURS

The invention concerns quinoline derivatives of Formula I Formula (I) wherein Z is an O, S, SO, SO2, N(R2) or C(R2)(R3) group wherein each R2 or R3 group is hydrogen or (1-8C)alkyl, m is 1, 2 or 3, each R1 group has any of the meanings defined in the description, Ra is hydrogen or halogeno, Rc is hydrogen, halogeno, (1-6C)alkyl or (1-6C)alkoxy, and Rd is (1-6C)alkoxy, or Rc and Rd together form a (1-3C)alkylenedioxy group, or a pharmaceutically-acceptable salt thereof; processes for their preparation; pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an anti-invasive agent in the containment and/or treatment of solid tumour disease.

PYRAZINIL QUINAZOLINE DERIVATIVES FOR USE IN THE TREATMENT OF TUMOURS

The invention concerns quinazoline derivatives of Formula (I) wherein Z is an O, S, SO, SO2, N(R2) or C(R2)(R3) group wherein each R2 or R3group is hydrogen or (1-8C)alkyl, m is 1, 2 or 3,